Black Raspberries May Prevent Colon Cancer

By LabMedica International staff writers
Posted on 30 Nov 2010
Black raspberries have been found to be highly effective in preventing colorectal tumors in two mouse models of the disease, according to recent research.

The study's findings are published in the November 2010 issue of the journal Cancer Prevention Research. Colorectal cancer is the third most common cancer and the second leading cause of cancer-related death in both men and women in the United States, according to the US National Cancer Institute.

Building on earlier research that found black raspberries have antioxidant, anticancer, antineurodegenerative, and anti-inflammatory properties, the researchers looked at the fruit's ability to prevent colon cancer. "We saw the black raspberry as a natural product, very powerful, and easy to access,” said Dr. Wancai Yang, assistant professor of pathology at the University of Illinois at Chicago (UIC) College of Medicine (IL, USA) and senior author of the study, whose research centers on the interactions of genetic and nutritional factors in the development of intestinal cancer and tumor prevention.

The researchers used two strains of mice, Apc1638 and Muc2, which each have a specific gene knocked out, causing the mice to develop either intestinal tumors (in the case of Apc1638) or colitis in the case of Muc2. Colitis is an inflammation of the large intestine that can contribute to the development of colorectal cancer.

Both mouse strains were randomized to be fed either a Western-style, high-risk diet (high in fat and low in calcium and vitamin D) or the same diet supplemented with 10% freeze-dried black raspberry powder for 12 weeks. The researchers discovered that in both mouse strains the black raspberry-supplemented diet produced a wide range of protective effects in the intestine, colon, and rectum and suppressed tumor formation.

In the Apc1638 mice, tumor incidence was reduced by 45% and the number of tumors by 60%. The researchers found that black raspberries inhibited tumor development by suppressing a protein, known as beta-catenin, which binds to the APC gene. In the Muc2 mice, tumor incidence and the number of tumors were both reduced by 50%, and black raspberries inhibited tumor development by reducing chronic inflammation associated with colitis.

The researchers now hope to obtain funding to begin clinical trials in humans, according to Dr. Yang. Because black raspberries not only prevent cancer but also inflammation, they may also protect against other diseases, such as heart disease.

Related Links:
University of Illinois at Chicago College of Medicine



Latest BioResearch News